Thalamic volume reduction in drug‐naive patients with new‐onset genetic generalized epilepsy

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|59|1|226-234

ISSN： 0013-9580

Source： EPILEPSIA, Vol.59, Iss.1, 2018-01, pp. : 226-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, double‐blind comparison of antiepileptic drug treatment in the elderly with new‐onset focal epilepsy

By  

EPILEPSIA, Vol. 56, Iss. 3, 2015-03 ,pp. : 450-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suspected new‐onset autoimmune temporal lobe epilepsy with amygdala enlargement

By  

EPILEPSIA, Vol. 57, Iss. 9, 2016-09 ,pp. : 1485-1494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of First‐Line Treatment With Recombinant Interleukin‐1 Receptor Antagonist in Steroid‐Naive Patients With New‐Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 4, 2014-04 ,pp. : 1034-1043

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical features of new‐onset systemic lupus erythematosus in pregnant patients

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 44, Iss. 2, 2018-02 ,pp. : 234-240

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antisaccades and executive dysfunction in early drug‐naive Parkinson's disease: The discovery study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 843-847

John Wiley & Sons Inc

Access to resources Recommend Favorite